Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

• Status: Recruiting
• Trial end date: 2021-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

Interventional, randomised, prospective, monocentric study

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Institut Jean-Godinot
• Treatments: Acetaminophen; Analgesics

Criteria

Inclusion Criteria:

• menopausal patient

• achieved histologically confirmed non-metastatic breast cancer with positive hormonal receptors

• starting an adjuvant anti-hormonal treatment with an AI

• patient benefiting from a social protection scheme

• patient mastering the French language -signature of free and informed consent -

Exclusion Criteria:

• patient whose treatment with chemotherapy or radiotherapy is ongoing or anticipated during the theoretical period of the study or patient who has completed her chemotherapy treatment within a period of less than 4 weeks prior to the inclusion visit

• patient with proven inflammatory rheumatism already diagnosed with rheumatoid arthritis, lupus, psoriatic rheumatism, ankylosing spondylitis -concomitant treatment with other complementary medicines (excepted Vitamin D), unless the treatment has been stable for at least 1 month.

• current treatment with narcotic drugs or corticosteroids

• patient with overexpressing breast cancer HER2